The recommendation statement from the Canadian Task Force on Preventive Health Care about preventing osteoporosis and osteoporotic fractures in postmenopausal women1 mentions oral pamidronate as a second-line drug choice. However, to the best of my knowledge, oral pamidronate is not available in Canada.
Mario L. de Lemos British Columbia Cancer Agency Vancouver, BC
Footnotes
Competing interests: None declared.
Reference
- 1.Cheung AM, Feig DS, Kapral M, Diaz-Granados N, Dodin S and The Canadian Task Force on Preventive Health Care. Prevention of osteoporosis and osteoporotic fractures in postmenopausal women: recommendation statement from the Canadian Task Force on Preventive Health Care. CMAJ 2004;170(11):1665-7. [DOI] [PMC free article] [PubMed]